ACTUP Capsule History 1989


January 19, 1989: The Housing Committee meets with Mayor Kochs' top housing advisor Caryn Schwab to discuss the lack of action on AIDS housing. Representatives from almost every N.Y. City agency attend. Schwab defends the Koch administration record, while the Housing Committee gained information for future actions.

January 31, 1989: The Housing Committee meets with HRA Commissioner Grinker to discuss the lawsuit Mixon vs Grinker, which tried to force the Koch administration to provide appropriate housing for people with AIDS and HIV.

February 2, 1989: ACT UP protests the FDA's new protocols for the drug DHPG (Gancyclovir), which would deny many current DHPG users access to the drug. Due to this action, the FDA makes DHPG available under "compassionate use" while it reconsiders its protocols.

February 11, 1989: Soup Kitchen rally at Grand Army Plaza in front of Trump Plaza. A coalition of groups protest the city's failure to respond to homelessness in the face of the tax breaks given to Donald Trump.

March 2, 1989: Protests and continued pressure at the FDA pay off. The FDA approves the use of DHPG, the only drug available to treat cytomegalovirus, which can cause retinitis, pneumonia and colitis.

March 28, 1989: ACT UP's second anniversary protest draws 3,000 to New York's City Hall, making "Target City Hall" the largest AIDS activist demonstration to date. ACT UP protests the inadequacy of New York's AIDS policy under Mayor Edward Koch. About 200 are arrested.

April 21, 1989: ACT UP/NY joins ACT UP/Atlanta to protest a South Carolina provision that would allow PWAs to be quarantined. The same day, using steel plates and rivets, four ACT UP members barricade themselves into a Burroughs Wellcome office in North Carolina. They demand a cut in the price of AZT, still the most expensive medicine in history at $8,000 for a year's dosage.

May 2, 1989: Based on the testimony of AIDS activists, the FDA Advisory Committee finally recognizes DHPG and Aerosolized Pentamadine for approval.

June 4-9, 1989: ACT UP demonstrates at the Fifth International Conference on AIDS in Montreal calling for a significant change in AIDS treatment research. ACT UP presents the revolutionary concept of parallel track drug testing, in which drugs already found to be non-toxic are placed in both clinical trials and released simultaneously to patients who do not qualify for the trials.

The next week, ACT UP members are invited to discuss parallel track with Dr. Anthony Fauci, Director of the AIDS program at the National Institute of Allergy and Infectious Diseases. Days later, Fauci announces parallel track publicly, and the government appoints a panel (including an ACT UP member) to write procedural standards.

That same week, ACT UP meets with Bristol Myers, the manufacturer of the anti-retroviral ddI, to demand ddI's release to patients who can no longer tolerate AZT. DdI is soon released to 5,000 patients.

September 14, 1989: ACT UP once again makes history by stopping trading on the Stock Exchange floor. Seven ACT UP members infiltrate the New York Stock Exchange and chain themselves to the VIP balcony. Their miniature foghorn